The I-Mab team from L-R: CFO Jielun Zhu; President Zheru Zhang; Founder and chairman Jingwu Zang; CEO Joan Shen; and chief commercial officer Ivan Yifei Zhu

I-Mab in talks about deals, stake sale to build on $3B Ab­b­Vie al­liance — Bloomberg

A year af­ter I-Mab made head­lines with its $2.9 bil­lion deal li­cens­ing a CD47 drug to Ab­b­Vie, the Chi­nese biotech is re­port­ed­ly hold­ing ear­ly talks …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.